4
Changes in Ownership
Arbutus Biopharma Corp Filed Acc 0001123292-18-001115
Options or other derivatives
- Chief Accounting Officer acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
VandenEnden Koert · Chief Accounting Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-12-11 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +7,500 | 7,500 | D |
Loading xslF345X03/edgar.xml…